2026 NPPES data Radiation Oncology Physician NPI 1194266544 M.D.
Verify on CMS →

SAMER SALAMEKH, M.D.

Radiation Oncology Physician in JACKSONVILLE, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
159
Medicare Part D claims · 71 beneficiaries · Radiation Oncology Physician avg: 186
Generic prescribing
87%
generic claims · 13% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
89.5963/100
▲ 6 pts above national avg 83.1 · [object Object]
Industry payments
$1.1K
7 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

SAMER SALAMEKH, M.D. reported a CMS MIPS final score of 89.5963/100 — above the 83.1 national average — and filed 159 Medicare Part D claims in 2023.

89.5963/100
MIPS score · +6 vs avg
159
Part D claims, 2023
87%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

SAMER SALAMEKH, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

90 Top 42% higher than 58% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

SAMER SALAMEKH, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about SAMER SALAMEKH, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 03/18/2017

NPI 1194266544

Primary specialty

Radiation Oncology Physician

Mid-sized

6,018 US NPIs in this specialty

Medicare Part D claims

159 15% vs specialty avg

2023 prescription claims

Specialty avg: 186

MIPS final score

89.5963/100 6.496300000000005% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Florida

How Radiation Oncology Physician compares to other specialties among Florida providers

Florida providers

Radiation Oncology Physician share within Florida

1. Radiation Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Radiation Oncology Physician share within Florida

Medicare quality performance — MIPS

SAMER SALAMEKH, M.D.'s 2023 MIPS final score plotted against the Radiation Oncology Physician national average

High performer (top quartile)
MIPS Final Score
89.5963/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Radiation Oncology Physician) — 89.5963/100 vs national avg 83.1

0%100%National avg83%89.6%
MIPS final score (Radiation Oncology Physician) — 89.5963/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SAMER SALAMEKH, M.D. appears in the CMS NPPES registry as a Radiation Oncology Physician provider holding M.D. credentials at 2 SHIRCLIFF WAY, JACKSONVILLE, FL, 32204, with a listed phone of (904) 388-2619. NPI 1194266544 was issued on 03/18/2017. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SALAMEKH most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 159 prescription claims written by this provider, covering 71 Medicare beneficiaries and totaling roughly $5K in drug spend, split 13% brand-name and 87% generic by claim count, with an opioid prescribing rate of 22.0%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 89.5963/100 for the 2023 performance year, compared with the national average of 83.1.

Radiation Oncology Physician is a mid-sized specialty nationwide, with 6,018 enrolled providers across 52 states and an average of 186 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2 SHIRCLIFF WAY
JACKSONVILLE, FL 32204

Provider Details

NPI 1194266544
Specialty Radiation Oncology Physician
Credentials M.D.
Gender Male
NPI Issued 03/18/2017

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

89.5963
Final Score
Avg: 83.1
84
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where SAMER SALAMEKH, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

CANCER SPECIALISTS LLC
JACKSONVILLE, FL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SAMER SALAMEKH, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$1.1K

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to SAMER SALAMEKH, M.D.. To verify SAMER SALAMEKH, M.D.'s current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

SAMER SALAMEKH, M.D. — brand share 13.0%
Specialty average (est.)

13% brand-name claims vs 87% generic, on 159 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

159
Total Claims
$5K
Total Drug Cost
71
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
167
Total Day Supply
3,000
Brand vs Generic
13% brand / 87% generic
Brand Drug Cost
$3K
Generic Drug Cost
$2K
Opioid Claims
35 (22.0% rate)

Patient Demographics

Average Patient Age
71.1 years
Avg HCC Risk Score
1.99
Gender Split
62% female / 38% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What SAMER SALAMEKH, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Methylprednisolone
14
Gabapentin
12
Oxycodone Hcl
11
Pantoprazole Sodium
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Radiation Oncology Physician Overview

How SAMER SALAMEKH, M.D. fits within the Radiation Oncology Physician landscape nationally.

6,018
Radiation Oncology Physician Providers in US
52
States with Radiation Oncology Physician
186
Avg Claims per Provider

SAMER SALAMEKH, M.D.'s 159 claims are below the specialty average of 186.

Nearby Radiation Oncology Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as SALAMEKH.

Compare Radiation Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is SAMER SALAMEKH, M.D.'s specialty?
SAMER SALAMEKH, M.D. specializes in Radiation Oncology Physician and practices in JACKSONVILLE, Florida. Credentials: M.D..
How much does SAMER SALAMEKH, M.D. prescribe under Medicare Part D?
In 2023, SAMER SALAMEKH, M.D. wrote 159 Medicare Part D claims totaling $5K in drug costs for 71 beneficiaries.
What is SAMER SALAMEKH, M.D.'s Medicare quality score?
SAMER SALAMEKH, M.D. has a CMS MIPS Final Score of 89.5963/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is SAMER SALAMEKH, M.D. located?
SAMER SALAMEKH, M.D. is located at 2 SHIRCLIFF WAY, JACKSONVILLE, FL, 32204. Phone: (904) 388-2619.
What is SAMER SALAMEKH, M.D.'s NPI number?
SAMER SALAMEKH, M.D.'s National Provider Identifier (NPI) is 1194266544, issued on 03/18/2017.
Does SAMER SALAMEKH, M.D. prescribe more brand-name or generic drugs?
SAMER SALAMEKH, M.D.'s prescribing is 13% brand-name and 87% generic drugs by claim count, with $3K in brand drug costs.
Does SAMER SALAMEKH, M.D. prescribe opioids?
Yes, SAMER SALAMEKH, M.D. had 35 opioid claims in 2023 with an opioid prescribing rate of 22.0%.
How many Radiation Oncology Physician providers are there in the US?
There are 6,018 Radiation Oncology Physician providers across 52 states in the US. The average Radiation Oncology Physician provider writes 186 Medicare Part D claims per year.
What drugs does SAMER SALAMEKH, M.D. prescribe most often?
Based on 2023 Medicare Part D data, SAMER SALAMEKH, M.D.'s most frequently prescribed drugs include Methylprednisolone, Gabapentin, Oxycodone Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SAMER SALAMEKH, M.D. accept Medicare?
SAMER SALAMEKH, M.D. appears in CMS Medicare data with 159 Part D claims and 71 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SAMER SALAMEKH, M.D.'s credentials?
SAMER SALAMEKH, M.D.'s NPI is 1194266544 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology